Roubaix Capital’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-441,008
Closed -$7.43M 55
2023
Q4
$7.43M Buy
441,008
+32,649
+8% +$462K 5.21% 1
2023
Q3
$6.12M Buy
408,359
+65,217
+19% +$1.1M 4.51% 3
2023
Q2
$6.46M Buy
343,142
+213,061
+164% +$3.39M 4.75% 2
2023
Q1
$2.33M Buy
+130,081
New +$2.17M 1.78% 29
2021
Q4
Sell
-102,612
Closed -$2.68M 53
2021
Q3
$2.68M Buy
+102,612
New +$2.48M 1.76% 32

Other funds holding SHC

Roubaix Capital's SHC Position: Q1 2024 in Review

Roubaix Capital sold out of Sotera Health (SHC) in Q1 2024, closing a stake of 441,008 shares — an estimated $7.43M sold.

Roubaix Capital first reported a position in SHC in Q3 2021 and held it in 5 quarters. The position peaked at $7.43M in Q4 2023. 196 funds tracked by Wall St. Rank hold SHC as of Q1 2024.

  • Roubaix Capital reported no remaining Sotera Health position as of Q1 2024 after selling out during the quarter.
  • Roubaix Capital sold 441,008 Sotera Health shares in Q1 2024, an estimated $7.43M.
  • Roubaix Capital first reported a position in Sotera Health in Q3 2021 and held it in 5 quarters.
  • Roubaix Capital's Sotera Health position peaked at $7.43M in Q4 2023.
  • 196 funds tracked by Wall St. Rank held Sotera Health as of Q1 2024.

Based on Roubaix Capital's 13F filing for Q1 2024, filed 13 May 2024.